Pre-treatment Neutrophil-to-Lymphocyte Ratio significantly affects progression free survival in positive EGFR mutation advanced lung adenocarcinoma with EGFR-TKI treatment in Bali, Indonesia Cover

.blurhash-client-img { display: none !important; }

Pre-treatment Neutrophil-to-Lymphocyte Ratio significantly affects progression free survival in positive EGFR mutation advanced lung adenocarcinoma with EGFR-TKI treatment in Bali, Indonesia

Romanian Journal of Internal Medicine

Volume 61 (2023): Issue 1 (March 2023)

By: Ni Putu Ayu Widiasari, Ida Bagus Ngurah Rai, Ida Ayu Jasminarti Dwi Kusumawardani, I Gede Ketut Sajinadiyasa, Ni Wayan Candrawati and Ni Luh Putu Eka Arisanti

Open Access

|Mar 2023

Download Article

Download the full article as a PDF file.

DOI: https://doi.org/10.2478/rjim-2022-0020 | Journal eISSN: 2501-062X | Journal ISSN: 1220-4749

Journal RSS Feed

Language: English

Page range: 63 - 71

Submitted on: Oct 1, 2022

Published on: Mar 16, 2023

Published by: N.G. Lupu Internal Medicine Foundation

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

adenocarcinoma,

Neutrophil-to-Lymphocyte Ratio,

Tyrosine Kinase Inhibitor,

Progression Free Survival

Related subjects:

Clinical medicine,

Internal medicine,

Internal medicine, other,

Gastroenterology,

© 2023 Ni Putu Ayu Widiasari, Ida Bagus Ngurah Rai, Ida Ayu Jasminarti Dwi Kusumawardani, I Gede Ketut Sajinadiyasa, Ni Wayan Candrawati, Ni Luh Putu Eka Arisanti, published by N.G. Lupu Internal Medicine Foundation
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous article Volume 61 (2023): Issue 1 (March 2023)